FUJIFILM Holdings Corporation's share price rose from ¥3,319 to ¥3,408 over the past 5 business days. Reports including the restart of a biopharmaceutical facility in the United States were cited as market catalysts. The earnings announcement date and latest developments are also provided.
In the latest price action, the share price rose 2.7% from ¥3,319 to ¥3,408 over the 5 business days from 29 September to 6 October, with trading continuing within a range amid gains on 30 September and 5 October. Reports on 2 September said that a U.S. biopharmaceutical facility had resumed operations in September after addressing regulatory requirements, and the share price rebounded that day after falling to ¥3,314 from the previous day's close.
In earnings-related developments, the next earnings announcement is scheduled for 9 November 2026. In the summary of results announced on 2026/8/6, revenue for the first quarter of the fiscal year ending March 2027 rose 10.3% year on year to ¥826.5 billion, while operating profit fell 32.0% to ¥51.2 billion and net profit fell 30.4% to ¥37.4 billion, reflecting higher fixed costs at the Healthcare segment's biopharmaceutical CDMO business and one-time expenses.